history of glp 1 agonists GLP-1 Receptor Agonist Market Growth Analysis GLP-1 receptor agonists and next-generation

Diabetes Medication Matchmaker Answer these questions to discover which diabetes medication class might align best with your health profile and goals

Available from: _Product_Information/human/002445/WC500140401.pdf

Clinically, these findings should be considered when treating patients with DPP-4i, especially in those patients with HF

The side effects are pretty similar to those of injections of the drug, and they can include nausea, diarrhea and vomiting

When to seek medical advice: If you experience muscle pain, weakness, or dark urine whilst taking statins (potential signs of myopathy) If severe, persistent abdominal pain occurs whilst on GLP-1 therapy (potential pancreatitis) If cholesterol reduction is not achieved despite treatment adherence Before stopping or changing any prescribed medication If you develop new symptoms or side effects from any therapy Patients should discuss their individual cardiovascular risk profile and treatment options with their GP or specialist

A study published in The Lancet in June 2023 reveals that over half a billion people globally are living with diabetes, impacting individuals of all ages and genders in every country